1 / 3

Hypoparathyroidism - Market Trends and Epidemiology Forecast

Hypoparathyroidism is characterized by hypocalcemia and hyperphosphatemia due to a lack of parathyroid hormone (PTH) secretion or action. Hypoparathyroidism may occur as part of a pluriglandular autoimmune disorder or as a complex congenital defect, for example in the autosomal dominant DiGeorge or hypoparathyroidism, deafness, and renal dysplasia (HDR) syndromes

xmichael
Download Presentation

Hypoparathyroidism - Market Trends and Epidemiology Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hypoparathyroidism Market Insights and Epidemiology Forecast Hypoparathyroidism is characterized by hypocalcemia and hyperphosphatemia due to a lack of parathyroid hormone (PTH) secretion or action. Hypoparathyroidism may occur as part of a pluriglandular autoimmune disorder or as a complex congenital defect, for example in the autosomal dominant DiGeorge or hypoparathyroidism, deafness, and renal dysplasia (HDR) syndromes. Hypoparathyroidism Epidemiology Segmentation in the 7MM ● ● ● ● ● ● Prevalent Cases of Hypoparathyroidism Diagnosed Prevalent Cases of Hypoparathyroidism Type-specific Diagnosed Prevalent Cases of Hypoparathyroidism Gender-specific Diagnosed Prevalent Cases of Hypoparathyroidism Cause-specific Diagnosed Prevalent Cases of Hypoparathyroidism Age-specific Diagnosed Prevalent Cases of Hypoparathyroidism Hypoparathyroidism Epidemiological Insights Observed in the 7MM (2021) ● ● ● The total prevalent population of Hypoparathyroidism in the 7MM was found to be 280k. The total prevalent population of Hypoparathyroidism in the UK are estimated to be 34.5k. The total prevalent population of Hypoparathyroidism in Japan are found to be 22.3k. Hypoparathyroidism Market Insight The market size of Hypoparathyroidism in the 7MM was found to be USD 235 million in 2021. Hypoparathyroidism Market Drivers ● ● ● Rising prevalence of neck surgeries and autoimmune diseases Rising awareness Presence of major players Hypoparathyroidism Market Barriers ● ● ● Knowledge gap Poor quality of life Availability of generics and off-label therapies Hypoparathyroidism Emerging Therapies The emerging drugs in the Hypoparathyroidism market are ● ● ● TransCon PTH EB612 Encaleret (BBP-305/CLTX-305), and many others

  2. Hypoparathyroidism Key Players The key players working in the Hypoparathyroidism market are ● ● ● ● Ascendis Pharma EnteraBio Bridgebio Calcilytix Therapeutics, and many others

More Related